Effects of d-norgestrel-releasing intracervical devices in the nonhuman primate, Erythrocebus patas.
Primates (Erythrocebus patas) were implanted with intracervical devices which slowly released d-norgestrel at either of two rates: 38 +/- 12 microgram/day (high dose, 4 animals) or 14 +/- 10 microgram/day (low dose, 3 animals). An additional 8 animals received placebo devices or were untreated controls. All animals were studied for 3 months of exposure, at which time they were necropsied and evaluated. The uterus in all of the high dose primates had endometrial stromal and epithelial hyperplasia and, in two primates, suppurative endometritis. Similar, but less severe, uterine changes were present in animals of the low dose group. Systemic effects included evidence of diminished menstrual cycling and an absence of corpora lutea at both dose levels. Our results indicate that local application of these levels of d-norgestrel for contraception produces effects similar to those from systemically administered d-norgestrel.
D000818:Animals; D002582:Cervix Mucus; D002584:Cervix Uteri / Q000473:pathology; D003274:Contraceptive Devices, Female; D004305:Dose-Response Relationship, Drug; D004901:Erythrocebus patas; D005260:Female; D009644:Norgestrel; D011374:Progesterone / Q000097:blood; D014599:Uterus / Q000473:pathology
D009644:Norgestrel; D011374:Progesterone